Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BRTXBioRestorative Therapies, Inc.

Nasdaq · CIK 0001505497
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC8090 Services-Misc Health & Allied Services, NEC
FY end1231
XBRL facts426

Identity from submissions API

NameBioRestorative Therapies, Inc.
CIK0001505497
TickersBRTX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC8090 Services-Misc Health & Allied Services, NEC
EIN301341024
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone(631) 760-8100
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Stem Cell Assurance, Inc. (2010-11-16T05:00:00.000Z → 2011-08-16T04:00:00.000Z)
Business address
40 MARCUS DRIVE
SUITE ONE
MELVILLE
NY
NY
Mailing address
40 MARCUS DRIVE
SUITE ONE
MELVILLE
NY
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

756 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-26-120589 001-37603 261560257 34 25219
2026-11-12 8-K CURRENT REPORT 5.02,9.01 0001213900-26-119019 001-37603 261547910 34 196593 1 1
2026-10-09 8-K CURRENT REPORT 5.02,9.01 0001213900-26-108467 001-37603 261452947 34 198696 1 1
2026-09-11 8-K CURRENT REPORT 5.02,9.01 0001213900-26-099018 001-37603 261372874 34 193171 1 1
2026-09-10 8-K/A AMENDMENT NO. 1 TO FORM 8-K 4.01,8.01,9.01 0001213900-26-098820 001-37603 261371484 34 215360 1 1
2026-09-02 8-K CURRENT REPORT 3.03,5.03,7.01,9.01 0001213900-26-096810 001-37603 261356065 34 235542 1 1
2026-09-02 8-K CURRENT REPORT 4.01,5.02,9.01 0001213900-26-096337 001-37603 261352055 34 482915 1 1
2026-08-25 8-K CURRENT REPORT 3.01,9.01 0001213900-26-093566 001-37603 261316678 34 193962 1 1
2026-08-14 NT 10-Q NT 10-Q 0001493152-26-038425 001-37603 261282294 34 35251
2026-08-14 8-K 8-K 8.01,9.01 0001493152-26-038391 001-37603 261281933 34 201708 1 1
2026-08-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001094891-26-000263 005-86699 261233145 34 6827
2026-07-30 3 xslF345X06/ownership.xml 0001213900-26-083461 3220
2026-07-24 3 PRIMARY DOCUMENT 0002146283-26-000001 3021
2026-07-16 8-K 8-K 5.02,9.01 0001493152-26-033593 001-37603 261181333 34 1484483 1 1
2026-06-18 3 xslF345X06/ownership.xml 0001213900-26-070160 3164
2026-06-18 3 xslF345X06/ownership.xml 0001213900-26-069973 3203
2026-06-17 3 xslF345X06/ownership.xml 0001213900-26-069704 3189
2026-06-12 8-K CURRENT REPORT FILING 5.02,9.01 0001021771-26-000093 001-37603 261087737 34 249967 1 1
2026-06-12 8-K CURRENT REPORT FILING 1.01,5.02,9.01 0001021771-26-000091 001-37603 261087683 34 345460 1 1
2026-05-29 8-K FORM 8-K DATED MARCH 26, 2026 5.02,5.07,9.01 0001021771-26-000084 001-37603 261045884 34 1025738 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001700205-26-000004 005-86699 26986233 34 81080
2026-05-14 10-Q 10-Q 0001493152-26-023126 001-37603 26979627 34 4553343 1 1
2026-05-01 8-K CURRENT REPORT FILING 5.02 0001021771-26-000068 001-37603 26932810 34 235196 1 1
2026-04-30 424B3 424B3 0001493152-26-020495 333-293322 26925366 33 208293
2026-04-28 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001353 333-293322 26910252 33 1869
2026-04-27 POS AM POS AM 0001493152-26-019129 333-293322 26900858 33 244739
2026-04-23 8-K CURRENT REPORT FILING 7.01,9.01 0001021771-26-000058 001-37603 26889697 34 10359985 1 1
2026-04-20 POS AM POS AM 0001493152-26-018143 333-293322 26876143 33 586621 1 1
2026-04-13 DEF 14A def14a.htm 0001021771-26-000042 001-37603 26858573 34 2779636
2026-04-03 PRE 14A PRELIMINARY PROXY STATEMENT NOT RELATED TO A CONTESTED MATTER OR MERGER/ACQUISIT 0001021771-26-000039 001-37603 26837742 34 109809
2026-03-26 10-K 10-K 0001493152-26-012925 001-37603 26798548 34 10551128 1 1
2026-02-23 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002027680-26-000001 005-86699 26666025 34 6501
2026-02-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-26-017939 005-86699 26648405 34 16929
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001700205-26-000003 005-86699 26639614 34 81161
2026-02-17 8-K 8-K 1.01,7.01,9.01 0001493152-26-006837 001-37603 26635684 34 362215 1 1
2026-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001896206-26-000003 005-86699 26633184 34 7066
2026-02-13 424B4 424B4 0001493152-26-006580 333-293322 26629401 33 2576430
2026-02-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000543 333-293322 26623107 33 1856
2026-02-10 CORRESP filename1.htm 0001021771-26-000020 9625
2026-02-10 S-1/A S-1/A 0001493152-26-006012 333-293322 26617313 33 429769 1 1
2026-02-09 S-1 S-1 0001493152-26-005827 333-293322 26612635 33 12609437 1 1
2025-12-19 DRS filename1.htm 0001493152-25-028561 377-08843 251587714 33 461683
2025-12-19 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002027680-25-000006 005-86699 251587126 34 6701
2025-12-12 424B3 PROSPECTUS RE 508,592 SHARES OF COMMON STOCK 0001021771-25-000152 333-291623 251569073 33 167990
2025-12-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003635 333-291623 251563423 33 1857
2025-12-08 CORRESP filename1.htm 0001021771-25-000150 8108
2025-11-18 S-8 S-8 0001493152-25-024082 333-291624 251495472 33 241525 1 1
2025-11-18 S-1 S-1 0001493152-25-024081 333-291623 251495424 33 588157 1 1
2025-11-12 10-Q 10-Q 0001493152-25-021993 001-37603 251474001 34 4395435 1 1
2025-11-12 8-K THIRD QUARTER 2025 FINANCIAL RESULTS 2.02,7.01,9.01 0001021771-25-000148 001-37603 251472842 34 4737870 1 1
2025-10-20 4 xslF345X05/form4.xml 0001021771-25-000141 17736
2025-10-20 4 xslF345X05/form4.xml 0001021771-25-000140 13447
2025-10-09 D xslFormDX01/primary_doc.xml 06b 0001021771-25-000134 021-560305 251384234 33 11225
2025-10-08 8-K 8-K 1.01,3.02,7.01,9.01 0001493152-25-017446 001-37603 251383077 34 648924 1 1
2025-10-08 424B5 424B5 0001493152-25-017433 333-269631 251382597 33 419719
2025-10-06 424B5 424B5 0001493152-25-017037 333-269631 251376126 33 18807
2025-09-25 8-K ANNUAL MEETING VOTE 5.07 0001021771-25-000131 001-37603 251341309 34 163405 1 1
2025-08-14 8-K PRESENTATION MATERIALS 7.01,9.01 0001021771-25-000116 001-37603 251220864 34 16266209 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001604867-25-000015 005-86699 251217928 34 81142
2025-08-12 10-Q 10-Q 0001641172-25-023211 001-37603 251207234 34 4046054 1 1
2025-08-12 8-K Q2 2025 EARNINGS, BUSINESS UPDATE AND CONFERENCE CALL 2.02,7.01,9.01 0001021771-25-000113 001-37603 251206944 34 4461569 1 1
2025-08-08 DEF 14A DEF 14A 0001641172-25-022812 001-37603 251199366 34 4630914 1 1
2025-06-13 8-K PRESENTATION - INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH 7.01,9.01 0001021771-25-000092 001-37603 251044812 34 16513118 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001700205-25-000001 005-86699 25950203 34 80948
2025-05-14 10-Q 10-Q 0001641172-25-010299 001-37603 25946241 34 3649914 1 1
2025-05-14 8-K FIRST QUARTER 2025 AND BUSINESS UPDATE CONFERENCE CALL 2.02,7.01,9.01 0001021771-25-000079 001-37603 25945599 34 4712054 1 1
2025-04-21 8-K CHANGE IN ACCOUNTANTS 4.01,9.01 0001021771-25-000074 001-37603 25853211 34 168642 1 1
2025-03-28 10-K form10-k.htm 0001641172-25-001011 001-37603 25781182 34 10455398 1 1
2025-03-27 8-K FINANCIAL RESULTS YEAR ENDED DECEMBER 31, 2024 AND CONFERENCE CALL 2.02,7.01,9.01 0001021771-25-000066 001-37603 25779380 34 2843914 1 1
2025-02-28 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002027680-25-000003 005-86699 25682754 34 6107
2025-02-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001021771-25-000050 005-86699 25641088 34 46347
2025-02-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001021771-25-000048 005-86699 25641009 34 59344
2025-02-19 4 xslF345X05/form4.xml 0001021771-25-000046 8782
2025-02-19 4 xslF345X05/form4.xml 0001021771-25-000044 8824
2025-02-19 4 xslF345X05/form4.xml 0001021771-25-000042 8769
2025-02-19 4 xslF345X05/form4.xml 0001021771-25-000040 10172
2025-02-19 4 xslF345X05/form4.xml 0001021771-25-000038 16830
2025-02-19 4 xslF345X05/form4.xml 0001021771-25-000036 11373
2025-02-19 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002027680-25-000002 005-86699 25637205 34 6114
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002027680-25-000001 005-86699 25606093 34 6113
2025-02-10 8-K ORS PRESENTATION 7.01,9.01 0001021771-25-000031 001-37603 25603757 34 20329149 1 1
2024-12-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002027680-24-000004 005-86699 241530075 34 6093
2024-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001700205-24-000004 005-86699 241459452 34 80964
2024-11-13 8-K THIRD QUARTER RESULTS AND ORS PRESENTATION 2.02,7.01,9.01 0001021771-24-000195 001-37603 241454167 34 15303306 1 1
2024-11-13 S-8 s8111324.htm 0001021771-24-000194 333-283197 241454086 33 64979
2024-11-12 10-Q form10-q.htm 0001493152-24-044763 001-37603 241448395 34 4764187 1 1
2024-11-07 8-K ADDITIONAL PRELIMINARY PHASE 2 DATA AND REVIEW OF THIRD QUARTER CONFERENCE CALL 7.01,9.01 0001021771-24-000190 001-37603 241432463 34 3712586 1 1
2024-11-06 8-K RODMAN & RENSHAW AT THE MARKET OFFERING AGREEMENT 1.01,1.02,9.01 0001021771-24-000188 001-37603 241431746 34 550679 1 1
2024-11-06 424B5 PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED FEBRUARY 14, 2023 0001021771-24-000186 333-269631 241431664 33 297416
2024-11-06 10-K/A form10-ka.htm 0001493152-24-043839 001-37603 241431430 34 413299 1 1
2024-11-05 4 xslF345X05/form4.xml 0001021771-24-000184 5063
2024-09-23 8-K SHAREHOLDER VOTE 5.07 0001021771-24-000180 001-37603 241316597 34 165569 1 1
2024-08-13 10-Q form10-q.htm 0001493152-24-031636 001-37603 241202177 34 4354017 1 1
2024-08-13 8-K SECOND QUARTER RESULTS 2.02,7.01,9.01 0001021771-24-000166 001-37603 241201540 34 4498345 1 1
2024-08-08 DEF 14A ANNUAL MEETING PROXY STATEMENT 0001021771-24-000160 001-37603 241188792 34 1962538
2024-08-06 8-K PRESS RELEASE RE SECOND QUARTER RESULTS AND CONFERENCE CALL 2.02,7.01,9.01 0001021771-24-000158 001-37603 241180115 34 2485340 1 1
2024-06-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002027680-24-000002 005-86699 241061678 34 6558
2024-06-11 10-Q form10-q.htm 0001493152-24-023481 001-37603 241036170 34 3968355 1 1
2024-06-11 10-K/A form10-ka.htm 0001493152-24-023479 001-37603 241036108 34 11384701 1 1
2024-05-24 8-K RE DELISTING 3.01 0001021771-24-000142 001-37603 24985225 34 156871 1 1
2024-05-24 8-K RE: RESTATEMENT 4.02 0001021771-24-000140 001-37603 24985158 34 162937 1 1
2024-05-16 NT 10-Q MARCH 31, 2024 0001021771-24-000130 001-37603 24956779 34 25484
2024-04-19 424B3 2,513,686 SHARES OF COMMON STOCK 0001021771-24-000111 333-278488 24858318 33 190651
2024-04-18 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-18 17:00:00 9999999995-24-001030 333-278488 24855498 33 1832
2024-04-17 CORRESP filename1.htm 0001021771-24-000103 6948
2024-04-12 S-1/A AMENDMENT NO. 1 0001021771-24-000099 333-278488 24842149 33 97540
2024-04-11 UPLOAD filename1.pdf 0000000000-24-003948 333-278488 40489
2024-04-10 4 xslF345X05/form4.xml 0001021771-24-000091 19542
2024-04-03 S-1 S-1 0001021771-24-000084 333-278488 24818985 33 374981
2024-04-01 10-K form10-k.htm 0001493152-24-012056 001-37603 24805054 34 9417866 1 1
2024-03-20 4 xslF345X05/form4.xml 0001021771-24-000079 16978
2024-03-20 4 xslF345X05/form4.xml 0001021771-24-000077 10328
2024-03-12 8-K RE PRESENTATION MATERIALS 7.01,9.01 0001021771-24-000068 001-37603 24740189 34 22003251 1 1
2024-03-06 SC 13D/A SCHEDULE 13D AMENDMENT 9 0001021771-24-000065 005-86699 24726442 34 61406
2024-02-15 SC 13D/A SCHEDULE 13D/AMENDMENT 2 0001021771-24-000060 005-86699 24644452 34 86804
2024-02-15 SC 13D/A SCHEDULE 13D AMENDMENT 2 0001021771-24-000058 005-86699 24644410 34 86433
2024-02-15 4 xslF345X05/form4.xml 0001021771-24-000056 7795
2024-02-15 4 xslF345X05/form4.xml 0001021771-24-000054 7837
2024-02-15 4 xslF345X05/form4.xml 0001021771-24-000052 8067
2024-02-15 4 xslF345X05/form4.xml 0001021771-24-000050 8091
2024-02-15 4 xslF345X05/form4.xml 0001021771-24-000048 8657
2024-02-15 4 xslF345X05/form4.xml 0001021771-24-000046 19428
2024-02-15 4 xslF345X05/form4.xml 0001021771-24-000044 10422
2024-02-14 SC 13G/A brtx_13gv2.htm 0001700205-24-000002 005-86699 24635671 34 110562
2024-02-12 4 xslF345X05/form4.xml 0001021771-24-000038 10325
2024-02-09 4 xslF345X05/form4.xml 0001021771-24-000035 10161
2024-02-08 8-K FORM 8-K DATED FEBRUARY 6, 2024 1.01,3.02,8.01,9.01 0001021771-24-000033 001-37603 24609150 34 548419 1 1
2024-02-05 8-K RE AUTOLOGOUS STEM CELL THERAPY POSTER 7.01,9.01 0001021771-24-000027 001-37603 24593988 34 2060866 1 1
2024-02-01 8-K PRESS RELEASE RE PRELIMINARY PHASE 2 CLINICAL TRIAL 7.01,9.01 0001021771-24-000025 001-37603 24587575 34 2451541 1 1
2023-12-05 4 xslF345X05/form4.xml 0001021771-23-000118 8692
2023-12-01 4 xslF345X05/form4.xml 0001021771-23-000116 8691
2023-11-15 S-8 REGISTRATION OF ADDITIONAL 1,350,000 UNDER 2021 STOCK INCENTIVE PLAN 0001021771-23-000112 333-275571 231410730 33 66326
2023-11-13 10-Q form10-q.htm 0001493152-23-040483 001-37603 231398620 34 3837207 1 1
2023-09-18 4 xslF345X05/form4.xml 0001021771-23-000098 10057
2023-09-18 4 xslF345X05/form4.xml 0001021771-23-000096 9578
2023-09-15 8-K SHAREHOLDER VOTE 5.07 0001021771-23-000094 001-37603 231259037 34 176718 1 1
2023-09-14 4 xslF345X05/form4.xml 0001021771-23-000092 10848
2023-09-13 4 xslF345X05/form4.xml 0001021771-23-000090 9580
2023-09-06 4 xslF345X05/form4.xml 0001021771-23-000088 9579
2023-08-31 4 xslF345X05/form4.xml 0001021771-23-000086 19410
2023-08-23 424B5 SUPPLEMENT NO. 3 TO PROSPECTUS SUPPLEMENT DATED APRIL 14, 2023 0001021771-23-000072 333-269631 231198248 33 15606
2023-08-11 10-Q form10-q.htm 0001493152-23-027825 001-37603 231164024 34 5943643 1 1
2023-08-04 DEF 14A 2023 ANNUAL MEETING PROXY STATEMENT 0001021771-23-000063 001-37603 231143961 34 1887983
2023-07-28 4 xslF345X05/form4.xml 0001140361-23-036665 8534
2023-07-25 4 xslF345X05/form4.xml 0001140361-23-036103 9540
2023-07-13 8-K FORM 8-K DATED JULY 11, 2023 1.01,8.01,9.01 0001021771-23-000057 001-37603 231085481 34 494127 1 1
2023-07-13 424B5 form424b5.htm 0001493152-23-024361 333-269631 231085455 33 375605
2023-07-11 424B5 SUPPLEMENT NO. 2 0001021771-23-000054 333-269631 231081222 33 12633
2023-05-15 424B5 SUPPLEMENT NO. 1 TO PROSPECTUS SUPPLEMENT DATED APRIL 14, 2023 0001021771-23-000043 333-269631 23924357 33 15844
2023-05-12 10-Q form10-q.htm 0001493152-23-016630 001-37603 23915593 34 3288088 1 1
2023-04-14 8-K form8-k.htm 1.01,9.01 0001493152-23-012377 001-37603 23822104 34 651140 1 1
2023-04-14 424B2 form424b2.htm 0001493152-23-012371 333-269631 23822040 33 381642
2023-04-06 8-K RE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT 8.01,9.01 0001021771-23-000037 001-37603 23806492 34 983478 1 1
2023-04-04 4 xslF345X04/form4.xml 0001021771-23-000034 19375
2023-03-28 S-8 FORM S-8 DATED MARCH 28, 2023 0001021771-23-000030 333-270909 23770495 33 65486
2023-03-27 10-K form10-k.htm 0001493152-23-008960 001-37603 23761130 34 7827102 1 1
2023-03-22 4 xslF345X04/form4.xml 0001021771-23-000028 19543
2023-03-22 4 xslF345X04/form4.xml 0001021771-23-000026 9230
2023-03-03 4 FORM 4 0001567619-23-004348 15657
2023-02-28 4 FORM 4 0001567619-23-003891 19760
2023-02-27 4 FORM 4 0001567619-23-003875 9488
2023-02-17 4 FORM 4 0001567619-23-003365 6903
2023-02-17 4 FORM 4 0001567619-23-003334 6779
2023-02-17 4 FORM 4 0001567619-23-003332 6820
2023-02-17 4 FORM 4 0001567619-23-003330 6850
2023-02-17 4 FORM 4 0001567619-23-003328 7460
2023-02-17 4 FORM 4 0001567619-23-003326 19634
2023-02-17 4 FORM 4 0001567619-23-003324 9362
2023-02-17 SC 13D/A AMENDMENT 1 0001021771-23-000022 005-86699 23644131 34 109723
2023-02-17 SC 13D/A AMENDMENT 1 0001021771-23-000021 005-86699 23644118 34 130264
2023-02-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-02-14 17:00:00 9999999995-23-000435 333-269631 23633484 33 1791
2023-02-14 SC 13G/A BRTX_13g_22_v5.htm 0001700205-23-000003 005-86699 23626067 34 110457
2023-02-13 CORRESP filename1.htm 0001021771-23-000014 7228
2023-02-13 S-3/A AMENDMENT 1 0001021771-23-000012 333-269631 23615252 33 485754
2023-02-10 UPLOAD filename1.pdf 0000000000-23-001435 40377
2023-02-07 S-3 COMMON STOCK, PREFERRED STOCK, WARRANTS, DEBT SECURITIES AND UNITS 0001021771-23-000010 333-269631 23596409 33 317575
2023-02-07 SC 13G/A BRTX 13GA 0001393825-23-000061 005-86699 23595653 34 57118
2023-02-02 4 FORM 4 0001567619-23-001697 8328
2023-01-30 4 FORM 4 0001567619-23-001399 7847
2023-01-24 4 FORM 4 0001567619-23-001186 9307
2023-01-20 4 FORM 4 0001567619-23-001056 10769
2023-01-10 4 FORM 4 0001567619-23-000770 7924
2023-01-05 8-K RE REINCORPORATION 3.03,9.01 0001021771-23-000002 001-37603 23512149 34 27905855 1 1
2022-12-28 4 FORM 4 0001567619-22-022055 9343
2022-12-07 4 FORM 4 0001567619-22-021408 8387
2022-11-21 4 FORM 4 0001567619-22-020707 19373
2022-11-21 4 FORM 4 0001567619-22-020651 8387
2022-11-14 10-Q form10-q.htm 0001493152-22-031668 001-37603 221380696 34 4230453 1 1
2022-11-09 8-K ANNUAL SHAREHOLDER MEETING 5.07 0001021771-22-000060 001-37603 221373416 34 178950 1 1
2022-11-04 4 FORM 4 0001567619-22-019201 7794
2022-11-04 4 FORM 4 0001567619-22-019198 24778
2022-11-04 4 FORM 4 0001567619-22-019195 8354
2022-11-04 4 FORM 4 0001567619-22-019193 7847
2022-11-04 4 FORM 4 0001567619-22-019191 7815
2022-11-04 4 FORM 4 0001567619-22-019189 7774
2022-11-04 4 FORM 4 0001567619-22-019187 13312
2022-10-12 4 FORM 4 0001567619-22-018437 19426
2022-10-12 4 FORM 4 0001567619-22-018424 19905
2022-10-04 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001021771-22-000056,2022-10-04 9999999995-22-002911 333-258611 221294450 33 1805
2022-09-30 POS AM AMENDMENT 1 TO POST EFFECTIVE AMENDMENT 1 TO FORM S-1 ON FORM S-3 0001021771-22-000056 333-258611 221285047 33 805096
2022-09-27 4 FORM 4 0001567619-22-017856 11404
2022-09-23 DEF 14A ANNUAL MEETING PROXY STATEMENT 0001021771-22-000053 001-37603 221262474 34 2404597
2022-09-23 4 FORM 4 0001567619-22-017754 9403
2022-09-13 8-K FORM 8-K RE CERTIFICATE OF DESIGNATION SERIES B 1.01,4.01,5.03,7.01,9.01 0001021771-22-000051 001-37603 221241140 34 22795180 1 1
2022-09-09 4 FORM 4 0001567619-22-017246 24726
2022-08-16 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ON FORM S-3 0001021771-22-000048 333-258611 221170307 33 810335
2022-08-15 10-Q form10-q.htm 0001493152-22-022617 001-37603 221162661 34 4823209 1 1
2022-08-05 PRE 14A 2022 ANNUAL MEETING PROXY STATEMENT 0001021771-22-000042 001-37603 221140972 34 2901385
2022-07-15 4 FORM 4 0001567619-22-014051 14721
2022-07-14 SC 13G BRTX_13g_22_v1.htm 0001700205-22-000002 005-86699 221083654 34 109188
2022-07-13 4 FORM 4 0001567619-22-013928 8474
2022-07-05 4 FORM 4 0001567619-22-013688 11886
2022-07-01 4 FORM 4 0001567619-22-013553 8479
2022-06-23 424B3 1,856,938 SHARES OF COMMON STOCK 0001021771-22-000031 333-265052 221036198 33 127373
2022-06-23 4 FORM 4 0001567619-22-013309 13305
2022-06-21 SC 13D/A DALE BROADRICK SCHEDULE 13D AMENDMENT 8 0001021771-22-000029 005-86699 221026449 34 77253
2022-06-17 4 FORM 4 0001567619-22-013111 13790
2022-06-17 4 FORM 4 0001567619-22-013067 8489
2022-06-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-06-16 17:00:00 9999999995-22-001804 333-265052 221022308 33 1792
2022-06-15 4 FORM 4 0001567619-22-012912 5949
2022-06-15 4 FORM 4 0001567619-22-012910 8494
2022-06-15 4 FORM 4 0001567619-22-012901 11886
2022-06-15 4 FORM 4 0001567619-22-012893 20674
2022-06-15 4 FORM 4 0001567619-22-012867 8495
2022-06-14 4 FORM 4 0001567619-22-012812 9470
2022-06-13 CORRESP filename1.htm 0001021771-22-000027 7289
2022-06-13 4 FORM 4 0001567619-22-012747 13789
2022-06-09 4 FORM 4 0001567619-22-012605 13791
2022-06-09 4 FORM 4 0001567619-22-012581 8010
2022-06-08 4 FORM 4 0001567619-22-012496 21152
2022-06-07 4 FORM 4 0001567619-22-012430 13790
2022-06-07 4 FORM 4 0001567619-22-012416 5949
2022-06-06 4 FORM 4 0001567619-22-012367 11885
2022-06-03 4 FORM 4 0001567619-22-012250 11885
2022-06-03 4 FORM 4 0001567619-22-012211 8008
2022-06-01 4 FORM 4 0001567619-22-012010 11888
2022-05-31 4 FORM 4 0001567619-22-011949 13784
2022-05-27 4 FORM 4 0001567619-22-011807 8495
2022-05-20 UPLOAD filename1.pdf 0000000000-22-005592 40257
2022-05-18 S-3 PROSPECTUS DATED MAY 13, 2022 0001021771-22-000025 333-265052 22939162 33 287154
2022-05-16 10-Q form10-q.htm 0001493152-22-013396 001-37603 22924242 34 4480935 1 1
2022-05-02 4 FORM 4 0001567619-22-009300 9456
2022-04-11 4 FORM 4 0001567619-22-008332 5949
2022-04-08 4 FORM 4 0001567619-22-008301 11402
2022-04-07 4 FORM 4 0001567619-22-008245 12823
2022-04-07 SC 13D/A DALE BROADRICK SCHEDULE 13D AMENDMENT 7 0001021771-22-000019 005-86699 22813937 34 60053
2022-04-01 4 FORM 4 0001567619-22-007864 14566
2022-03-30 10-K form10k.htm 0001493152-22-008184 001-37603 22787138 34 17175037 1 1
2022-03-29 4 FORM 4 0001567619-22-007664 22696
2022-03-29 SC 13D/A DALE BROADRICK SCHEDULE 13D AMENDMENT 6 0001021771-22-000014 005-86699 22781586 34 79478
2022-03-22 4 FORM 4 0001567619-22-007349 22032
2022-03-22 4 FORM 4 0001567619-22-007347 8173
2022-02-14 SC 13G/A AMENDMENT TO SC 13G 0001387131-22-001750 005-86699 22624491 34 101837
2022-02-02 SC 13G BRTX 13G 0001393825-22-000015 005-86699 22584083 34 61624
2022-01-24 4 FORM 4 0001567619-22-001588 7840
2022-01-05 4 FORM 4 0001567619-22-000585 7841
2022-01-04 SC 13G/A SABBY 13G-A BRTX 1.04.22 0001535610-22-000030 005-86699 22505588 34 13321
2021-12-08 8-K RE CFO 5.02,9.01 0001021771-21-000099 001-37603 211479225 34 274135 1 1
2021-12-02 4 FORM 4 0001567619-21-021415 7840
2021-11-23 4 FORM 4 0001567619-21-021072 7842
2021-11-23 RW REQUESTFORWITHDRAWAL 0001021771-21-000097 333-231079 211438768 NE 6112
2021-11-22 4 FORM 4 0001567619-21-020992 7841
2021-11-22 4 FORM 4 0001567619-21-020924 23369
2021-11-19 8-K 8-K DATED NOVEMBER 16, 2021 RE AUTHORIZED SHARE REDUCTION 5.03,9.01 0001021771-21-000092 001-37603 211427597 34 1038098 1 1
2021-11-16 4 FORM 4 0001567619-21-020595 12697
2021-11-16 4 FORM 4 0001567619-21-020585 25047
2021-11-16 4 FORM 4 0001567619-21-020581 5376
2021-11-16 3 FORM 3 0001567619-21-020579 3660
2021-11-16 SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-21-011159 005-86699 211413750 34 97317
2021-11-15 10-Q form10q.htm 0001493152-21-028733 001-37603 211412243 34 6642852 1 1
2021-11-15 8-K FORM 8-K DATED NOVEMBER 9, 2021 RE PUBLIC OFFERING 3.02,7.01,9.01 0001021771-21-000089 001-37603 211411973 34 12419868 1 1
2021-11-09 SC 13G SABBY 13G BRTX 11.09.21 0001535610-21-000099 005-86699 211391007 34 13321
2021-11-09 424B4 form424b4.htm 0001493152-21-027544 333-258611 211389181 33 3159733
2021-11-08 4 FORM 4 0001567619-21-019510 5368
2021-11-08 3 FORM 3 0001567619-21-019508 3651
2021-11-08 4 FORM 4 0001567619-21-019503 5409
2021-11-08 3 FORM 3 0001567619-21-019500 3693
2021-11-08 4 FORM 4 0001567619-21-019498 29066
2021-11-08 4 FORM 4 0001567619-21-019496 5441
2021-11-08 4 FORM 4 0001567619-21-019494 11535
2021-11-08 8-K FORM 8-K DATED NOVEMBER 4, 2021 1.01,5.02,7.01,9.01 0001021771-21-000087 001-37603 211388853 34 14783500 1 1
2021-11-04 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-11-04 17:00:00 9999999995-21-004196 333-258611 211382145 33 1792
2021-11-04 S-1MEF forms-1mef.htm 0001493152-21-027276 333-260792 211381884 33 78905
2021-11-04 CERT 8A_Cert_BRTX.pdf 0001354457-21-001292 001-37603 211379880 34 216090
2021-11-04 8-A12B REGISTRATION OF COMMON STOCK 0001021771-21-000082 001-37603 211379736 34 14452
2021-11-04 CORRESP filename1.htm 0001021771-21-000080 5139
2021-11-04 CORRESP filename1.htm 0001021771-21-000078 9489
2021-11-04 S-1/A forms-1a.htm 0001493152-21-027195 333-258611 211378221 33 16751491 1 1
2021-10-29 S-1/A forms-1a.htm 0001493152-21-026766 333-258611 211364426 33 16581595 1 1
2021-10-26 8-K FORM 8-K DATED OCTOBER 26, 2021 RE REVERSE SPLIT 5.03,8.01,9.01 0001021771-21-000076 001-37603 211349549 34 2544616 1 1
2021-10-20 8-K FORM 8-K DATED OCTOBER 14, 2021 1.01,9.01 0001021771-21-000074 001-37603 211334868 34 6684321 1 1
2021-10-18 S-1/A forms-1a.htm 0001493152-21-025629 333-258611 211327145 33 15686321 1 1
2021-08-17 8-K 8-K DATED AUGUST 17, 2021 RE: SHAREHOLDER VOTE 5.07 0001021771-21-000066 001-37603 211183244 34 177111 1 1
2021-08-16 10-Q form10-q.htm 0001493152-21-019979 001-37603 211175337 34 5902913 1 1
2021-08-13 UPLOAD filename1.pdf 0000000000-21-009978 40267
2021-08-12 DEFA14A DEFINITIVE ADDITIONAL PROXY MATERIALS 0001021771-21-000061 001-37603 211168050 34 34785
2021-08-06 S-1 forms-1.htm 0001493152-21-018939 333-258611 211155495 33 3460029
2021-07-19 DEFA14A definitiveaddmaterials.htm 0001021771-21-000057 001-37603 211098145 34 26848
2021-07-07 DEF 14A ANNUAL MEETING OF STOCKHOLDERS AUGUST 17, 2021 0001021771-21-000049 001-37603 211076332 34 2689433
2021-06-25 PRE 14A PRELIMINARY PROXY STATEMENT RE ANNUAL MEETING 0001021771-21-000042 001-37603 211048496 34 915056
2021-05-17 10-Q form10-q.htm 0001493152-21-011738 001-37603 21929144 34 4241378 1
2021-04-30 S-8 S-8 REGISTRATION STATEMENT 0001021771-21-000034 333-255681 21879112 33 123709
2021-04-30 10-K form10-k.htm 0001493152-21-010062 001-37603 21872475 34 7438634 1
2021-04-12 10-Q form10-q.htm 0001493152-21-008499 001-37603 21819655 34 5050581 1
2021-04-12 10-Q form10-q.htm 0001493152-21-008498 001-37603 21819605 34 4751979 1
2021-04-05 8-K/A FORM 8-K AMENDMENT NO. 1 5.02,9.01 0001021771-21-000028 001-37603 21806064 34 23694
2021-04-01 NT 10-K BIORESTORATIVE THERAPIES, INC. FORM 12B-25 10-K 2020 0001021771-21-000026 001-37603 21798567 34 26255
2021-03-29 10-Q form10-q.htm 0001493152-21-006978 001-37603 21779401 34 4305739 1
2021-03-19 3 FORM 3 0001567619-21-006694 3634
2021-03-19 4 FORM 4 0001567619-21-006692 27907
2021-03-19 4 FORM 4 0001567619-21-006690 7309
2021-03-19 SC 13D FRANCISCO SILVA SCHEDULE 13D 0001021771-21-000024 005-86699 21758863 34 44590
2021-03-19 SC 13D LANCE ALSTODT SCHEDULE 13D 0001021771-21-000022 005-86699 21758834 34 44189
2021-03-19 8-K BIORESTORATIVE FORM 8-K DATED MARCH 18, 2021 5.02,9.01 0001021771-21-000020 001-37603 21758806 34 523777
2021-03-18 10-K form10-k.htm 0001493152-21-006285 001-37603 21751962 34 9294382 1
2021-01-06 8-K FORM 8-K DATED JANUARY 5, 2021 RE: LETTER TO SHAREHOLDERS 7.01,9.01 0001021771-21-000002 001-37603 21511415 34 3684264
2020-12-04 8-K FORM 8-K DATED DECEMBER 1, 2020 RE: CHANGE IN ACCOUNTANTS 4.01,9.01 0001021771-20-000083 001-37603 201370182 34 510585
2020-11-24 4 FORM 4 0001567619-20-020268 4859
2020-11-24 4 FORM 4 0001567619-20-020265 25454
2020-11-20 8-K FORM 8-K DATED NOVEMBER 16, 2020 RE: REORGANIZATION 1.03,2.03,3.02,5.02,5.03,9.01 0001021771-20-000081 001-37603 201333144 34 57156
2020-11-05 8-K FORM 8-K DATED OCTOBER 30, 2020 RE: ORDER OF BANKRUPTCY COURT 1.03,9.01 0001021771-20-000079 001-37603 201291275 34 26716294
2020-04-28 8-K FORM 8K DATED APRIL 23, 2020 1.01,1.03,9.01 0001021771-20-000044 001-37603 20825273 34 124529
2020-04-03 8-K FORM 8-K DATED MARCH 30, 2020 1.01,1.03,9.01 0001021771-20-000041 001-37603 20774130 34 696013
2020-03-31 NT 10-K FORM 12B-25 FOR PERIOD ENDED DECEMBER 31, 2019 0001021771-20-000038 001-37603 20761871 34 29529
2020-03-20 8-K FORM 8-K DATED MARCH 16, 2020 1.01,1.03,2.04,5.02,7.01,9.01 0001021771-20-000036 001-37603 20731999 34 757777
2020-03-05 8-K FORM 8-K DATED FEBRUARY 28, 2020 3.02 0001021771-20-000031 001-37603 20691126 34 16822
2020-02-26 8-K FORM 8-K DATED FEBRUARY 20, 2020 1.01,2.03,3.02,5.02,9.01 0001021771-20-000029 001-37603 20655869 34 33270286
2020-02-20 8-K FEBRUARY 20, 2020 3.02 0001021771-20-000027 001-37603 20635709 34 27184
2020-02-14 8-K FORM 8-K DATED FEBRUARY 13, 2020 7.01 0001021771-20-000025 001-37603 20621235 34 16012
2020-02-11 8-K FORM 8-K DATED FEBRUARY 10, 2020 2.04,3.02,7.01,9.01 0001021771-20-000023 001-37603 20598264 34 1845269
2020-02-07 8-K form8k020320.htm 3.02,7.01 0001021771-20-000019 001-37603 20587984 34 20350
2020-01-31 8-K FORM 8-K DATED JANUARY 27, 2020 3.02 0001021771-20-000014 001-37603 20566079 34 17497
2020-01-24 8-K FORM 8-K DATED JANUARY 20, 2020 3.02 0001021771-20-000012 001-37603 20546135 34 16704
2020-01-16 8-K FORM 8-K DATED JANUARY 10, 2020 3.02,5.02 0001021771-20-000008 001-37603 20531406 34 19495
2020-01-10 8-K FORM 8-K DATED JANUARY 8, 2020 3.02,5.02,5.07,9.01 0001021771-20-000006 001-37603 20521905 34 1580087
2020-01-09 SC 13D/A DALE BROADRICK SCHEDULE 13D AMENDMENT NO. 5 0001021771-20-000004 005-86699 20516810 34 52258
2020-01-08 4 FORM 4 0001567619-20-000794 13255
2020-01-07 8-K BIORESTORATIVE FORM 8-K DATED DECEMBER 31, 2019 3.02 0001021771-20-000002 001-37603 20513956 34 16050
2019-12-27 SC 13G SCHEDULE 13G 0001078782-19-000952 005-86699 191311326 34 44416
2019-12-26 8-K FORM 8-K DATED DECEMBER 19, 2019 1.01,3.02 0001021771-19-000098 001-37603 191310908 34 18293
2019-12-23 DEF 14A def14a.htm 0001493152-19-019634 001-37603 191306886 34 276162
2019-12-18 8-K FORM 8-K DATED DECEMBER 12, 2019 3.02 0001021771-19-000096 001-37603 191293260 34 17425
2019-12-13 PRE 14A JANUARY 8, 2020 SPECIAL MEETING 0001021771-19-000094 001-37603 191285389 34 1824491
2019-12-10 4 FORM 4 0001567619-19-022842 42363
2019-12-10 SC 13D/A DALE BROADRICK SCHEDULE 13D AMENDMENT 4 0001021771-19-000092 005-86699 191278474 34 57914
2019-12-06 8-K FORM 8-K DATED DECEMBER 2, 2019 3.02 0001021771-19-000089 001-37603 191273490 34 16782
2019-11-26 8-K FORM 8-K DATED NOVEMBER 20, 2019. 3.02 0001021771-19-000087 001-37603 191252181 34 17785
2019-11-15 8-K FORM 8-K DATED NOVEMBER 13, 2019 RE: SPECIAL MEETING 5.07,9.01 0001021771-19-000083 001-37603 191224961 34 1674203
2019-11-13 10-Q form10-q.htm 0001493152-19-017053 001-37603 191214706 34 5279314 1
2019-11-05 8-K FORM 8-K DATED OCTOBER 30, 2019 3.02 0001021771-19-000081 001-37603 191194045 34 16684
2019-11-01 DEFA14A ARENA PURCHASE AGREEMENT TERMINATION 0001021771-19-000079 001-37603 191187604 34 18425
2019-11-01 8-K FORM 8-K DATED NOVEMBER 1, 2019 RE: ARENA PURCHASE AGREEMENT TERMINATION 1.02 0001021771-19-000077 001-37603 191187573 34 13537
2019-11-01 SC 13D/A DALE BROADRICK SCHEDULE 13D AMENDMENT NO. 3 0001021771-19-000075 005-86699 191187224 34 53766
2019-11-01 4 FORM 4 0001567619-19-020298 17229
2019-10-28 DEF 14A NOVEMBER 2019 SPECIAL MEETING PROXY STATEMENT 0001021771-19-000073 001-37603 191173650 34 2078468
2019-10-22 8-K FORM 8-K DATED OCTOBER 16, 2019 1.01,3.02,9.01 0001021771-19-000071 001-37603 191162113 34 19607
2019-10-18 PRE 14A PRELIMINARY PROXY STATEMENT SPECIAL MEETING NOVEMBER 12, 2019 0001021771-19-000069 001-37603 191158852 34 2091402
2019-10-18 SC 13D/A DALE BROADRICK - BIORESTORATIVE THERAPIES, INC. SCHEDULE 13D AMENDMENT 2 0001021771-19-000063 005-86699 191157930 34 154431
2019-10-18 4 FORM 4 0001567619-19-019742 59105
2019-10-18 4/A FORM 4/A 0001567619-19-019733 12416
2019-10-10 8-K 8-K OCTOBER 7, 2019 1.01,2.03,3.02,9.01 0001021771-19-000061 001-37603 191146714 34 187326
2019-10-04 8-K FORM 8-K DATED SEPTEMBER 30, 2019 3.02 0001021771-19-000056 001-37603 191139011 34 16352
2019-09-10 4 FORM 4 0001567619-19-018128 10342
2019-09-06 S-1/A forms-1a.htm 0001493152-19-013825 333-231079 191080442 33 12656799 1
2019-09-06 8-K FORM 8-K DATED AUGUST 30, 2019 3.02,5.07,7.01,9.01 0001021771-19-000051 001-37603 191080356 34 15519162
2019-09-06 4 FORM 4 0001567619-19-018008 7511
2019-09-06 4 FORM 4 0001567619-19-018006 26572
2019-09-06 4 FORM 4 0001567619-19-018004 22358
2019-09-03 4 FORM 4 0001567619-19-017786 27990
2019-09-03 4 FORM 4 0001567619-19-017784 13879
2019-08-29 4 FORM 4 0001567619-19-017679 15298
2019-08-29 4 FORM 4 0001567619-19-017677 18197
2019-08-29 4 FORM 4 0001567619-19-017673 22351
2019-08-28 4 FORM 4 0001567619-19-017635 26003
2019-08-27 4 FORM 4 0001567619-19-017607 8925
2019-08-27 4 FORM 4 0001567619-19-017605 18197
2019-08-27 8-K form8k82119.htm 3.02 0001021771-19-000049 001-37603 191058363 34 20487
2019-08-23 4 FORM 4 0001567619-19-017530 26002
2019-08-23 4 FORM 4 0001567619-19-017528 11742
2019-08-23 4 FORM 4 0001567619-19-017526 20932
2019-08-22 4 FORM 4 0001567619-19-017492 7504
2019-08-15 S-8 REGISTRATION OF 10,000,000 SHARES 0001021771-19-000047 333-233309 191030965 33 75398
2019-08-15 DEF 14A SPECIAL MEETING PROXY STATEMENT 0001021771-19-000045 001-37603 191030913 34 7032030
2019-08-14 10-Q form10-q.htm 0001493152-19-012593 001-37603 191027167 34 4911400 1
2019-08-02 PRE 14A PRELIMINARY PROXY STATEMENT RE: 2019 SPECIAL MEETING 0001021771-19-000042 001-37603 19996710 34 6385105
2019-08-01 8-K BIORESTORATIVE FORM 8-K DATED JULY 26, 2019 1.01,2.03,3.02,9.01 0001021771-19-000039 001-37603 19993371 34 1903977
2019-07-17 8-K FORM 8-K DATED JULY 11, 2019 3.02 0001021771-19-000037 001-37603 19959360 34 18910
2019-06-24 8-K FORM 8-K DATED JUNE 18, 2019 1.01,2.03,3.02,9.01 0001021771-19-000035 001-37603 19915278 34 34035365
2019-06-12 8-K FORM 8-K DATED JUNE 6, 2019 RE: ITEM 302 3.02 0001021771-19-000033 001-37603 19893921 34 18844
2019-06-04 8-K FORM 8-K RE: ANNUAL MEETING 5.07,9.01 0001021771-19-000030 001-37603 19874570 34 50535
2019-05-29 8-K FORM 8-K DATED MAY 22, 2019 3.02 0001021771-19-000028 001-37603 19862324 34 17434
2019-05-15 10-Q form10-q.htm 0001493152-19-007157 001-37603 19824691 34 3796123 1
2019-05-13 8-K FORM 8-K DATED MAY 7, 2019 1.01,3.02,9.01 0001021771-19-000026 001-37603 19819197 34 22372
2019-05-09 SC 13D/A DALE BROADRICK - BIORESTORATIVE THERAPIES, INC. SCHEDULE 13D AMENDMENT 1 0001021771-19-000024 005-86699 19811399 34 13078250
2019-05-09 4 FORM 4 0001567619-19-010301 27109
2019-04-30 8-K FORM 8-K RE: PRESENTATION 7.01,9.01 0001021771-19-000022 001-37603 19782126 34 11732849
2019-04-26 S-1 forms-1.htm 0001493152-19-006013 333-231079 19772412 33 9121183 1
2019-04-24 8-K FORM 8-K DATED APRIL 18, 2019 3.02 0001021771-19-000020 001-37603 19764426 34 19911
2019-04-18 DEF 14A BIORESTORATIVE PROXY STATEMENT APRIL 17, 2019 0001021771-19-000018 001-37603 19756376 34 2403686
2019-04-05 PRE 14A MAY 30, 2019 PROXY STATEMENT 0001021771-19-000016 001-37603 19735661 34 3694528

Latest XBRL company facts

One latest value per concept from companyfacts (426 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 25.48M 2026-05-14 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
dei EntityPublicFloat Entity Public Float USD 11.20M 2025-06-30 2025 FY 10-K 2026-03-26 0001493152-26-012925
ffd NetFeeAmt NetFeeAmt USD 0 2026-04-20 POS AM 2026-04-20 0001493152-26-018143
ffd TtlFeeAmt TtlFeeAmt USD 2,882.83 2026-04-20 POS AM 2026-04-20 0001493152-26-018143
ffd TtlOfferingAmt TtlOfferingAmt USD 20.88M 2026-04-20 POS AM 2026-04-20 0001493152-26-018143
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-20 POS AM 2026-04-20 0001493152-26-018143
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 2,882.83 2026-04-20 POS AM 2026-04-20 0001493152-26-018143
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 4 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001493152-17-013246
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 112,000 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 36,500 2018-12-31 2019 FY 10-K 2021-03-18 0001493152-21-006285
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 666,898 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 265,297 2019-09-30 2019 Q3 10-Q 2019-11-13 0001493152-19-017053
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 13,300 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap AccretionExpense Accretion Expense USD 2.81M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses USD 91,000 2018-12-31 2019 FY 10-K 2021-03-18 0001493152-21-006285
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 744,485 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 744,485 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 92,000 2019-09-30 2019 Q3 10-Q 2019-11-13 0001493152-19-017053
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 137,122 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap AccruedRentCurrent Accrued Rent, Current USD 7,865 2019-09-30 2019 Q3 10-Q 2019-11-13 0001493152-19-017053
us-gaap AccruedRentCurrentAndNoncurrent Accrued Rent USD 12,438 2019-12-31 2020 FY 10-K 2021-04-30 0001493152-21-010062
us-gaap AccruedSalariesCurrentAndNoncurrent Accrued Salaries USD 557,500 2019-12-31 2020 FY 10-K 2021-04-30 0001493152-21-010062
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.23M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 175.10M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap AdjustmentForAmortization Amortization USD -37,264 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001493152-21-019979
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 166,404 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 148,697 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.76M 2021-07-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028733
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 3.67M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 1.87M 2022-09-08 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031668
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 179,228 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD 7.99M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-13 0001493152-19-017053
us-gaap AdvertisingExpense Advertising Expense USD 288,986 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001493152-19-004292
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 290,215 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2023-12-31 2023 FY 10-K/A 2024-06-11 0001493152-24-023479
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 1.13M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 89,747 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 24.99M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap Assets Assets USD 4.64M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap AssetsCurrent Assets, Current USD 3.80M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 3.89M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021993
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 475,438 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 29,246 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0001641172-25-010299
us-gaap CapitalizedComputerSoftwareGross Capitalized Computer Software, Gross USD 85,118 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap Cash Cash USD 17.93M 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022617
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 3.11M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 4.90M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031668
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 7,185 2008-12-30 2011-06-30 2011 Q2 10-Q/A 2011-09-14 0001144204-11-053024
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 3.11M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 1.60M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2023-12-31 2023 FY 10-K/A 2024-06-11 0001493152-24-023479
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -346,306 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001493152-18-015801
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 2.84M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrant 0.75 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030532
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004554
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 4.50M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 4.50M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 12.88M 2021-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031668
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 75.00M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 25.48M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 25.48M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 23.00M 2021-11-09 2022 Q3 10-Q 2022-11-14 0001493152-22-031668
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,548 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 150,000 2025-03-31 2025 Q1 10-Q 2025-05-14 0001641172-25-010299
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 80,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001493152-16-015059
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 3.00M 2021-07-16 2021 Q2 10-Q 2021-08-16 0001493152-21-019979
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 7,385 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 102 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004554
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 228,932 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028733
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 6,250 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-22 0001493152-17-002701
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 1.56M 2019-05-01 2019-08-31 2019 Q3 10-Q 2019-11-13 0001493152-19-017053
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 75,000 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 5.89M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028733
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 14,103 2021-09-26 2021-09-27 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.1 2018-09-30 2018 Q3 10-Q 2018-11-13 0001493152-18-015801
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 250,000 2022-01-01 2022-12-31 2023 FY 10-K/A 2024-06-11 0001493152-24-023479
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 183,043 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028733
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 35,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001144204-14-067818
us-gaap DebtInstrumentIncreaseDecreaseOtherNet Debt Instrument, Increase (Decrease), Other, Net USD 73,058 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001144204-14-067818
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.15 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020255
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.79 2014-05-02 2014 Q3 10-Q 2014-11-13 0001144204-14-067818
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.166 2020-11-16 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap DebtInstrumentInterestRateStatedPercentageRateRangeMaximum Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum (Deprecated 2016-01-31) pure 0.15 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001144204-14-067818
us-gaap DebtInstrumentInterestRateStatedPercentageRateRangeMinimum Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum (Deprecated 2016-01-31) pure 0.08 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001144204-14-067818
us-gaap DebtInstrumentPeriodicPaymentInterest Debt Instrument, Periodic Payment, Interest USD 23,013 2019-01-01 2019-12-31 2020 FY 10-K 2021-04-30 0001493152-21-010062
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 25,000 2016-03-01 2016-03-04 2016 Q1 10-Q 2016-05-13 0001144204-16-101925
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 0 2020-12-31 2020 FY 10-K 2021-04-30 0001493152-21-010062
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 5.37M 2020-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 333,117 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-23 0001144204-15-067511
us-gaap DebtorInPossessionFinancingAmountArranged Debtor-in-Possession Financing, Amount Arranged USD 1.19M 2021-06-30 2021 Q2 10-Q 2021-08-16 0001493152-21-019979
us-gaap DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees Debtor Reorganization Items, Legal and Advisory Professional Fees USD 476,652 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts Debtor Reorganization Items, Write-off of Debt Issuance Costs and Debt Discounts USD -2.58M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 9,517 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 2.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 6.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 147,000 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap DeferredRevenue Deferred Revenue USD 80,700 2024-06-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031636
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap DeferredRevenueRevenueRecognized Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) USD 587,364 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-23 0001144204-15-067511
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 3.96M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 139,800 2013-12-31 2013 FY 10-K 2014-04-11 0001144204-14-022141
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 0 2013-12-31 2013 FY 10-K 2014-04-11 0001144204-14-022141
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 22.73M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 1.39M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 22.58M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 19.53M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 60.40M 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 600 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 330,000 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 188,800 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.29M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 22.58M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssets Deferred Tax Liabilities, Goodwill and Intangible Assets USD 30,000 2020-12-31 2020 FY 10-K 2021-04-30 0001493152-21-010062
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 29,400 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 39,000 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 37,600 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 0 2012-12-31 2012 FY 10-K 2013-04-02 0001144204-13-019421
us-gaap Depreciation Depreciation USD 120,238 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 52,394 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 80,877 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001493152-23-027825
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 1.22M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap DerivativeInstrumentsAndHedgesLiabilities Derivative Instruments and Hedges, Liabilities USD 1.54M 2023-12-31 2023 FY 10-K/A 2024-06-11 0001493152-24-023479
us-gaap DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net USD 4.00M 2023-01-01 2023-12-31 2023 FY 10-K/A 2024-06-11 0001493152-24-023479
us-gaap DerivativeLiabilities Derivative Liability USD 2.19M 2024-02-08 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.40M 2025-12-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 1.87M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031636
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 23.92M 2014-09-30 2014 Q3 10-Q 2014-11-13 0001144204-14-067818
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 8.33M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-19 0001144204-13-046897
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 68,000 2015-06-30 2015 Q2 10-Q 2015-08-14 0001144204-15-049960
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 87,030 2015-12-31 2016 FY 10-K 2017-03-22 0001493152-17-002701
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.12 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -37.3 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.12 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.204 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001493152-19-004292
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.434 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 1 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.621 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001493152-19-004292
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 6.00M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031668
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 746,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 704,000 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 1.06M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044763
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 1.18M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 10.80M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031668
us-gaap EntityWideRevenueMajorCustomerPercentage Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) pure 1 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-14 0001144204-12-045890
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 141,818 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-13 0001493152-19-017053
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 1.22M 2026-01-01 2026-02-24 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-09-29 2017-09-30 2017 Q3 10-Q 2017-11-14 0001493152-17-013246
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 1.11 2017-09-29 2017-09-30 2017 Q3 10-Q 2017-11-14 0001493152-17-013246
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.013 2017-09-29 2017-09-30 2017 Q3 10-Q 2017-11-14 0001493152-17-013246
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 696,804 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028733
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 167,434 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 89,747 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 14,603 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 82,920 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 89,747 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 89,747 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 534,198 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 126,150 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 39,476 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-22 0001493152-17-002701
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 3,970 2012-10-01 2012-10-18 2013 FY 10-K 2014-04-11 0001144204-14-022141
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -16.18M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 1.48M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap GrossProfit Gross Profit USD 15,785 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -14.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -14.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -8,912 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004554
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -9.44M 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004554
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-02 0001144204-13-019421
us-gaap IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-04-11 0001144204-14-022141
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -2.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -2.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 2,100 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 6.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -52,100 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -682,003 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -2,200 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -64,070 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 80,700 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-12 0001641172-25-023211
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 150,000 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 0 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-13 0001144204-16-101925
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD -4,415 2008-12-30 2011-06-30 2011 Q2 10-Q/A 2011-09-14 0001144204-11-053024
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD -3.48M 2023-01-01 2023-09-30 2023 FY 10-K/A 2024-06-11 0001493152-24-023479
us-gaap IncreaseDecreaseInFinanceReceivables Increase (Decrease) in Finance Receivables USD 2.00M 2012-03-03 2012-04-02 2013 FY 10-K 2014-04-11 0001144204-14-022141
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 120,552 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-22 0001493152-17-002701
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 547 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-14 0001493152-16-015059
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -162,317 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 25,938 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 22,100 2019-01-01 2019-12-31 2020 FY 10-K 2021-04-30 0001493152-21-010062
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 511,761 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap InterestAndDividendIncomeOperating Interest and Dividend Income, Operating USD 6,064 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap InterestAndDividendIncomeSecuritiesHeldToMaturity Interest Income, Debt Securities, Held-to-maturity USD 5,479 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap InterestExpense Interest Expense USD 104,465 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031668
us-gaap InterestExpenseDebt Interest Expense, Debt USD 6,769 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001493152-21-019979
us-gaap InterestExpenseOther Interest Expense, Other USD 75,624 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022617
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 266,207 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 11,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001493152-17-009275
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 983 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap InterestPayableCurrent Interest Payable, Current USD 532,005 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028733
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 54,159 2021-11-09 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap InventoryNet Inventory, Net USD 2,492 2015-09-30 2015 Q3 10-Q 2015-11-23 0001144204-15-067511
us-gaap InventoryWriteDown Inventory Write-down USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 112,847 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 4.12M 2008-12-30 2012-12-31 2012 FY 10-K 2013-04-02 0001144204-13-019421
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 74,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-13 0001493152-19-017053
us-gaap LeaseCost Lease, Cost USD 174,352 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 301,610 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap LegalFees Legal Fees USD 100,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-02 0001144204-13-019421
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 43,265 2024-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044763
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 173,060 2023-12-31 2023 FY 10-K/A 2024-06-11 0001493152-24-023479
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 173,060 2019-12-31 2019 FY 10-K 2021-03-18 0001493152-21-006285
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 173,060 2020-12-31 2020 FY 10-K 2021-04-30 0001493152-21-010062
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 173,060 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 173,060 2022-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 43,265 2024-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044763
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 851 2024-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044763
us-gaap Liabilities Liabilities USD 3.67M 2025-06-30 2025 Q2 10-Q 2025-08-12 0001641172-25-023211
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 4.64M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.61M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 1.97M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021993
us-gaap LiabilitiesSubjectToCompromise Liabilities Subject to Compromise USD 14.70M 2020-09-30 2020 Q3 10-Q 2021-04-12 0001493152-21-008499
us-gaap LiabilitiesSubjectToCompromiseAccountsPayableAndAccruedLiabilities Liabilities Subject to Compromise, Accounts Payable and Accrued Liabilities USD 2.13M 2020-09-30 2020 Q3 10-Q 2021-04-12 0001493152-21-008499
us-gaap LiabilitiesSubjectToCompromiseDebtAndAccruedInterest Liabilities Subject to Compromise, Debt and Accrued Interest USD 1.03M 2020-09-30 2020 Q3 10-Q 2021-04-12 0001493152-21-008499
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 21,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028733
us-gaap LoansPayable Loans Payable USD 250,000 2021-12-31 2023 FY 10-K/A 2024-06-11 0001493152-24-023479
us-gaap LoansPayableCurrent Loans Payable, Current USD 58,970 2021-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap LongTermDebt Long-term Debt USD 250,000 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 71,307 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 58,970 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 60,161 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 59,562 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 196,876 2010-12-31 2011 FY 10-K 2012-04-16 0001144204-12-021914
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 191,030 2021-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 4.27M 2020-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap LossContingencyDamagesPaidValue Loss Contingency, Damages Paid, Value USD 193,000 2013-11-01 2013-11-30 2014 FY 10-K 2015-03-31 0001144204-15-020255
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 18,970 2012-10-01 2012-10-18 2013 FY 10-K 2014-04-11 0001144204-14-022141
us-gaap MarketableSecurities Marketable Securities USD 479,351 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 479,351 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -18,598 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040483
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 714 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022617
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 4.44M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 715,085 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001493152-18-007130
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 968,447 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -3,617 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004554
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -3.81M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -1.16M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001493152-18-007130
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -2.15M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 291,055 2008-12-30 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030532
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.23M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap NotesPayable Notes Payable USD 250,000 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap NotesPayableCurrent Notes Payable, Current USD 58,970 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021993
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021993
us-gaap OperatingExpenses Operating Expenses USD 3.40M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -3.39M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap OperatingLeaseCost Operating Lease, Cost USD 174,352 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 42,414 2024-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044763
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 162,317 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 42,414 2023-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044763
us-gaap OperatingLeasePayments Operating Lease, Payments USD 174,352 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 151,447 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 184,572 2018-12-31 2018 FY 10-K 2019-03-29 0001493152-19-004292
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 147,257 2018-12-31 2018 FY 10-K 2019-03-29 0001493152-19-004292
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 37,315 2016-12-31 2016 FY 10-K 2017-03-22 0001493152-17-002701
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 37,315 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004554
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 37,315 2018-12-31 2018 FY 10-K 2019-03-29 0001493152-19-004292
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 97,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-23 0001144204-15-067511
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.12 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 59.90M 2022-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 947,739 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 657,598 2020-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 14,345 2019-09-30 2019 Q3 10-Q 2019-11-13 0001493152-19-017053
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 262,894 2017-09-30 2017 Q3 10-Q 2017-11-14 0001493152-17-013246
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 17,284 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031668
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 29,300 2019-01-01 2019-12-31 2020 FY 10-K 2021-04-30 0001493152-21-010062
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 5,728 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap OtherNotesPayable Other Notes Payable USD 392,685 2014-09-30 2014 Q3 10-Q 2014-11-13 0001144204-14-067818
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 540,280 2022-03-31 2022 Q1 10-Q 2022-05-16 0001493152-22-013396
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 89,063 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001144204-14-067818
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 226,500 2008-12-30 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030532
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 14,428 2019-01-01 2019-09-30 2020 Q3 10-Q 2021-04-12 0001493152-21-008499
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap PaymentsForRoyalties Payments for Royalties USD 100,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020255
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 395,715 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 500,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 559,164 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 175,000 2022-01-01 2022-12-31 2023 FY 10-K/A 2024-06-11 0001493152-24-023479
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 74,920 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 222,642 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031668
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 36,400 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2021-06-30 2021 Q2 10-Q 2021-08-16 0001493152-21-019979
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2021-06-30 2021 Q2 10-Q 2021-08-16 0001493152-21-019979
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 13,982 2025-12-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 194,378 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 436,181 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 65,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 8.12M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap ProceedsFromDerivativeInstrumentInvestingActivities Proceeds from Derivative Instrument, Investing Activities USD 2.48M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 4.40M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.08M 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 782,498 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028733
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 5.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 7.53M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031636
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 4.29M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 3.85M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001493152-21-019979
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 54,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-15 0001493152-17-005361
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 38,500 2018-01-01 2018-12-31 2019 FY 10-K 2021-03-18 0001493152-21-006285
us-gaap ProceedsFromRepaymentOfLoansToPurchaseCommonStock Proceeds from Repayment of Loans to Purchase Common Stock USD 30,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001493152-16-015059
us-gaap ProceedsFromRepaymentsOfDebt Proceeds from (Repayments of) Debt USD 250,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 1.04M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 42,411 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1.12M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap ProfessionalFees Professional Fees USD 121,521 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022617
us-gaap PropertyPlantAndEquipmentAdditions Property, Plant and Equipment, Additions USD 304,055 2010-01-01 2010-12-31 2012 FY 10-K 2013-04-02 0001144204-13-019421
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 101,423 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001493152-19-004292
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.59M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 328,810 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ReorganizationItems Reorganization Items USD -4.08M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap RepaymentsOfDebt Repayments of Debt USD -3.11M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-13 0001493152-19-017053
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 4.89M 2019-01-01 2019-12-31 2020 FY 10-K 2021-04-30 0001493152-21-010062
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 5,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap RepaymentsOfOtherShortTermDebt Repayments of Other Short-term Debt USD -5,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-22 0001493152-17-002701
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 38,500 2018-01-01 2018-12-31 2019 FY 10-K 2021-03-18 0001493152-21-006285
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 89,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-22 0001493152-17-002701
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.93M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 125,000 2013-12-31 2013 FY 10-K 2014-04-11 0001144204-14-022141
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -172.08M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 23,170 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap Revenues Revenues USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031636
us-gaap SalariesWagesAndOfficersCompensation Salary and Wage, Excluding Cost of Good and Service Sold USD 565,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020255
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 12.56M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 3.03 2023-07-13 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap SecurityDeposit Security Deposit USD 22,100 2018-12-31 2019 FY 10-K 2021-03-18 0001493152-21-006285
us-gaap SeveranceCosts1 Severance Costs USD 125,000 2015-03-02 2015-03-09 2014 FY 10-K 2015-03-31 0001144204-15-020255
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 290,215 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030532
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.18 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004554
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 0 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030532
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0.65 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030532
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.954 2025-10-08 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.991 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.987 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2025-10-08 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.043 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 100,000 2014-09-30 2014 Q3 10-Q 2014-11-13 0001144204-14-067818
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 12.61M 2022-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.75M 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040483
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 392,584 2025-03-31 2025 Q1 10-Q 2025-05-14 0001641172-25-010299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.20M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.67 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 126 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 53,210 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 11,219 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020255
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.88 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 566,088 2025-03-31 2025 Q1 10-Q 2025-05-14 0001641172-25-010299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.21M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.58 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 625 2015-06-30 2015 Q2 10-Q 2015-08-14 0001144204-15-049960
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 4 2016-09-30 2016 Q3 10-Q 2016-11-14 0001493152-16-015059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 700,000 2012-04-02 2013 FY 10-K 2014-04-11 0001144204-14-022141
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 1,442 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum pure 0.045 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022617
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 1.75 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001144204-14-067818
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 838,549 2022-09-14 2022-09-15 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award shares 629,017 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040483
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.45 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 5.08 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 1.82 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.44 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 532,045 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022617
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 864,609 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022617
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionExpense Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) USD 1.59M 2008-12-30 2012-12-31 2012 FY 10-K 2013-04-02 0001144204-13-019421
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued shares 31,473 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091575
us-gaap SharePrice Share Price USD/shares 1 2026-03-26 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap ShorttermDebtAverageOutstandingAmount Short-term Debt, Average Outstanding Amount USD 14.70M 2020-01-01 2020-09-30 2020 Q3 10-Q 2021-04-12 0001493152-21-008499
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 5.08M 2020-11-15 2020-11-16 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 290,215 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 3.03M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap StockIssued1 Stock Issued USD 317,376 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 136.56M 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-02 0001144204-13-019421
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 20,000 2013-03-21 2013-04-10 2013 Q1 10-Q 2013-05-15 0001144204-13-029629
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 678,125 2025-10-08 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 20,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001493152-17-013246
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 29,249 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 317,377 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-27 0001493152-23-008960
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 166,404 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 7,500 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 4.35M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 173 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 985,038 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 7,500 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001011
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 42,411 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap StockIssuedDuringPeriodValueTreasuryStockReissued Stock Issued During Period, Value, Treasury Stock Reissued USD -16,875 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004554
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 48,875 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001493152-16-015059
us-gaap TreasuryStockShares Treasury Stock, Shares shares 0 2016-12-31 2016 FY 10-K 2017-03-22 0001493152-17-002701
us-gaap TreasuryStockValue Treasury Stock, Value USD 32,000 2015-12-31 2016 FY 10-K 2017-03-22 0001493152-17-002701
us-gaap ValuationAllowanceAmount Valuation Allowance, Amount (Deprecated 2013-01-31) USD 4.74M 2012-12-31 2012 FY 10-K 2013-04-02 0001144204-13-019421
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 6.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012925
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 11,063 2015-12-31 2016 FY 10-K 2017-03-22 0001493152-17-002701
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 17.73M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 1.19M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001493152-22-008184
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 17.73M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023126

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →